Skip to content

Drug interactions

Alogliptin-pioglitazone + Glibenclamide

Severity: Moderate

Alogliptin-pioglitazone and Glibenclamide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Adding alogliptin and pioglitazone to glyburide increases the risk of hypoglycemia, which may be prolonged with glyburide, especially in older adults or renal impairment.

What this interaction means in plain words

Alogliptin-pioglitazone and Glibenclamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Alogliptin-pioglitazone belongs to Endocrine; Glibenclamide belongs to Endocrine.

Evidence level: High

Why it happens

Additive glucose-lowering effects from insulin secretagogue action, DPP-4 inhibition and insulin sensitization.

What to do

Consider reducing the glyburide dose when starting the combination. Monitor blood glucose and counsel on hypoglycemia.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Alogliptin-pioglitazone and Glibenclamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Alogliptin-pioglitazone with Glibenclamide?

MediHelp rates the interaction as moderate. Alogliptin-pioglitazone and Glibenclamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Adding alogliptin and pioglitazone to glyburide increases the risk of hypoglycemia, which may be prolonged with glyburide, especially in older adults or renal impairment.

How serious is the interaction between Alogliptin-pioglitazone and Glibenclamide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider reducing the glyburide dose when starting the combination. Monitor blood glucose and counsel on hypoglycemia.

What other medicines interact with Alogliptin-pioglitazone?

MediHelp also lists interactions of Alogliptin-pioglitazone with, for example, Gemfibrozil, Insulin aspart, Insulin degludec. The full list is on the Alogliptin-pioglitazone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in